12.05.2015 • NewsDistribution AgreementBrenntagHexion

Brenntag and Hexion Expand Distribution Agreement for Epoxy Resins to Austria

Brenntag and Hexion announced an expanded cooperation on Epoxy Resins in Austria, effective June 1, 2015.

The expanded agreement is said to strengthens the channel partner relationship the two companies have in Europe. Brenntag already represents Hexion in the following countries: Belgium, France, Germany, Italy, Luxembourg, the Netherlands, Portugal, Spain, Switzerland, the United Kingdom, Croatia, Czech Republic, Poland, Romania, Serbia, Slovakia and Slovenia.

"With this step to Austria, we expand our excellent business relationship with Hexion yet again, providing innovative new epoxy products, including water-based technologies designed to serve construction end-markets in a variety of coatings applications," said Martin Rimmer, European Marketing Manager, Coatings & Construction for Brenntag Europe, Middle East and Africa.

"We are pleased to further expand our relationship with Brenntag, which has an excellent track record representing our epoxy products and a strong sales force with the necessary technical knowledge and commitment to grow our joint business," said Wouter Jongepier, Business Director, Epoxy Specialties EMEA, Hexion. "Our two companies will provide improved service levels, stronger product stocking, and timely technical support to critical industries operating in Austria."

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.